Use of exogenous hormones by women and colorectal cancer: Evidence from the Royal College of General Practitioners' Oral Contraception Study

Contraception

Volumn 71, Issue 2, 2005, Pages 95-98

  Hannaford, Philip ^a   Elliott, Alison ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

Colorectal cancer; HRT; Oral contraceptives

Indexed keywords

ADULT; ARTICLE; CANCER RISK; COLORECTAL CANCER; CONFIDENCE INTERVAL; CONTROLLED STUDY; DATA BASE; FEMALE; FOLLOW UP; GENERAL PRACTITIONER; HORMONE SUBSTITUTION; HUMAN; MAJOR CLINICAL STUDY; MEDICAL RECORD; ORAL CONTRACEPTION; RISK REDUCTION;

EID: 13544276358     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.contraception.2004.08.003     Document Type: Article

References (15)

1. http://www3.who.int/whosis. [Accessed June 10, 2004].
2. http://www-dep.iarc.fr. [Accessed June 10, 2004].
3. E. Fernandez, C. La Vecchia, A. Balducci, L. Chatenoud, S. Francheschi, and E. Negri Oral contraceptives and colorectal cancer risk: a meta-analysis Br. J. Cancer 81 2001 722 727
4. F. Levi, C. Pasche, F. Lucchini, and C. La Vecchia Oral contraceptives and colorectal cancer Dig. Liver Dis. 35 2003 85 87
5. K.A. Rosenblatt, D.Li Gao, R.M. Ray, Z.C. Nelson, and D.B. Thomas Contraceptive methods and induced abortions and their association with the risk of colon cancer in Shanghai, China Eur. J. Cancer 40 2003 590 593
6. F. Grodstein, P.A. Newcomb, and M.J. Stampfer Postmenopausal hormone therapy and the risk of colorectal cancer: a review and meta-analysis Am. J. Med. 106 1999 574 582
7. I. Csizmadi, J.-P. Collett, A. Benedetti, J.-F. Boivin, and J.A. Hanley Defining hormone replacements therapy in longitudinal studies: impact on measures of effect Pharmacoepidemiol. Drug Saf. 13 2004 215 225
8. R.T. Chlebowski, J. Wactawski-Wende, and C. Ritenbaugh Estrogen plus progestin and colorectal cancer in postmenopausal women New Engl. J. Med. 350 2004 991 1004
9. The Women's Health Initiative Steering Committee Effects of conjugated equine estrogen in postmenopausal women with hysterectomy. The women's health initiative controlled trial JAMA 291 2004 1701 1712
10. Royal College of General Practitioners Oral contraceptives and health 1974 Pitman Medical London
11. T. Moorhead, P. Hannaford, and M. Warskyj Prevalence and characteristics associated with use of hormone replacement therapy in Britain Br. J. Obstet. Gynaecol. 104 1997 290 297
12. Epidemiological Graphics, Estimation and Testing (EGRET) [computer program]. Seattle (WA): Statistics and Epidemiology Research Corporation.
13. V. Beral, C. Hermon, C. Kay, P. Hannaford, S. Darby, and G. Reeves Mortality associated with oral contraceptives: 25-year follow-up of cohort of 46,000 women from the Royal College of General Practitioners' Oral Contraception Study BMJ 318 1999 96 100
14. V. Beral, C. Hermon, C. Kay, P.C. Hannaford, S. Darby, and G. Reeves Mortality in relation to method of follow-up in the Royal College of General Practitioners' Oral Contraception Study P.C. Hannaford A.M.C. Webb Evidence-guided prescribing of the pill 1996 Parthenon Publishing Group London 327 339
15. Royal College of Physicians of Edinburgh Consensus statement on hormone replacement therapy J. R. Coll. Phys. Edinb. 33 2003 273 274